Cited in Research Around the Globe
Recent News
Our Partners
Learn how the Cytocentric® approach can transform your research

We create precise, physiologically relevant environments that support increased cell viability, assay reproducibility, and data credibility.

The optimal care of cells enhances economic efficiency by reducing operation costs, gas and reagent use, and cleaning and supplies cost.

From Xvivo Systems® and environmental controllers to cell culture chambers, every BioSpherix solution is modular, configurable, and designed to meet the unique needs of your research or manufacturing workflow.
Cytocentric® technologies and solutions ensure higher quality cells for better quality data and experimental results.
Cited in Research Around the Globe
“I have used Biospherix small animal oxygen chambers in my research for over a decade, and they have served me exceptionally well. The chambers are reliable and well designed, even with long-term, routine use. Just as importantly, customer and technical support has always been prompt, friendly, and effective whenever I’ve needed assistance. Biospherix has been a dependable partner in my work.”
We first contacted the team when we were setting up our GMP facility in Bangkok, Thailand … The system is incredibly straight forward to learn and get comfortable with … The best part about the system is how well it maintains sterility, which ensures that we have a high rate of batch compliance. The team are also very responsive to any inquiries despite the time difference, and over the years we have built a great relationship with them.
The BioSpherix System provides an operational advantage through reduced processing times and less time spent gowning-up.
We provide a constant physiologic environment with the Xvivo, so we’re hitting the cells with only defined components and we know exactly what we’re changing. We put the cell at the center and it works.
If you could look into the future, this would be the future of organ transplantation…This is much more elegant and much safer. This is like a new chapter in medicine.
The Xvivo barrier isolator system for cells was the answer to our prayers. Their technology allowed us to safely build a new trachea for our patient and virtually eliminated the risk of contamination.
The enhanced flexibility of the system allows me to have reduced staffing and staff flexibility. Technicians efficiently move back and forth within reduced classification suites. In addition, the enhanced reagent flow in and out of the operating space is a plus for our multiple trials. Another advantage of the technology is our ability to separate our processes – if we make changes to one unit the rest of them are unchanged.
Bristol-Myers Squibb selected the BioSpherix Isolator for the soft, clear design of the isolator fact and its tactile gloves. We also especially liked the versatility provided by the modular units that made customizing modules of different configurations very easy. At FAT, the team was impressed with the ability of the Isolator to rapidly clear particle counts.
The other big advantage is between BioSpherix isolators vs. traditional stainless steel isolators, is that I can rearrange these modules however I want. That is a huge advantage when developing a strategy for cell therapy replacement. There’s a lot we don’t know, so modularity is key.
Thank you, BioSpherix, for the good equipment you have provided us. It gave us the necessary tools to study MSC in their adequate environments (Normoxia, Hypoxia and Anoxia). Well done!
Recent News
BioSpherix celebrates Grand Opening of the Center for Cytocentric Technology (CCT) in Parish, New York PARISH, N.Y. - May 18, 2026: BioSpherix officially celebrated the grand opening of its new Center for Cytocentric Technology (CCT) facility today with a...
May 18, 2026
BioSpherix now offering Biotech Bootcamp for scientists and science educators BioSpherix, the leader in modular, aseptic enclosures for cell and gene research, is excited to offer the first Biotech Bootcamp this summer 2026. This 4.5 day, hands-on workshop will...
Mar 4, 2026
MEDIA ALERT: BioSpherix launches Center for Cytocentric® Technology in Parish, NY BioSpherix, a global leader in Cytocentric® environmental control systems, has announced the launch of its new state-of-the-art facility, The Center for Cytocentric® Technology (CCT),...
Feb 25, 2026
BioSpherix validates new Dry Eye System in collaboration with Ichor Life Sciences for in vivo market launch. Parish, NY, USA, August 2025: BioSpherix, LLC (Parish NY) has announced the launch of its new Dry Eye System, engineered to deliver precise low relative...
Aug 5, 2025
BioSpherix and Cellbox Solutions announce strategic partnership to enable seamless closed-system cell processing the mobile transport. Parish, NY, USA / Rockville, MD, USA, July 2025:BioSpherix, LLC., a leader in closed-system cell culture and processing...
Jul 16, 2025





“ASEPTIC CELL PROCESSING AND PRODUCTION WITH NO CHEMICAL BIOCIDES” technology and systems is protected by US and international patents including:
And also including patent pending in Canada, Brazil, European, Indonesia, India, Malaysia, New Zealand, Singapore, and Thailand.
“Cytocentric” is a registered trademark of BioSpherix, LLC, as well as the following non-exclusive list of terms:
CYTOCENTRIC CELL INCUBATION AND PROCESSING SYSTEMS
XVIVO SYSTEM
BIOSPHERIX
CYTOCENTRIC
XVIVO GMP SYSTEM
Please contact sales@biospherix.com for more details





